Skip to main content
. 2020 Nov 12;17(22):8376. doi: 10.3390/ijerph17228376

Table 5.

Types of errors to be assessed during the study.

Phase 1 (Drug Preparation) Phase 2 (Drug Administration)
  • Defective connection of the needle to the syringe (both groups);

  • Non-compliance with aseptic technique during needle connection (both groups);

  • Incorrect drug dose or flushing volume after aspiration (in mL) (both groups);

  • Non-compliance with aseptic technique during drug/flushing aspiration (both groups);

  • Incorrect syringe labelling or label position (both groups);

  • Wrong chamber aspiration sequence (double-chamber group);

  • Aspiration of drug/flushing solution to the wrong chamber (double-chamber group);

  • Chamber contamination (double-chamber group).

  • Defective connection of the syringe to the catheter hub (both groups);

  • Non-compliance with aseptic technique during syringe-to-hub connection (both groups);

  • Incorrect administration of drug dose or flushing volume (in mL) (both groups);

  • Non-compliance with aseptic technique during drug/flushing administration (both groups);

  • Wrong administration sequence (both groups);

  • Non-compliance with the push–pause technique during catheter flushing (both groups);

  • Chamber contamination (double-chamber group);

  • Catheter accidental removal (both groups).